Form 8-K ZIOPHARM ONCOLOGY INC For: Oct 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Ziopharm Oncology, Inc. (ZIOP) Posts Q3 Loss of 6c/Share
October 30, 2014 4:14 PM EDTZiopharm Oncology, Inc. (NASDAQ: ZIOP) reported Q3 EPS of ($0.06), which may not compare with the analyst estimate of ($0.12). Revenue for the quarter came in at $633 thousand versus the consensus estimate of $3.43 million.
Included in the loss for the third quarter of 2014... More
